4//SEC Filing
Bonner Michael 4
Accession 0001209191-20-024880
CIK 0001087294other
Filed
Apr 16, 8:00 PM ET
Accepted
Apr 17, 5:18 PM ET
Size
6.3 KB
Accession
0001209191-20-024880
Insider Transaction Report
Form 4
Bonner Michael
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2020-03-18$3.53/sh−2,134$7,533→ 17,787 total - Award
Common Stock
2020-03-23$3.56/sh+2,500$8,900→ 20,287 total
Footnotes (2)
- [F1]This transaction represents shares purchased by the Company to cover the tax withholding obligations for the vesting of shares.
- [F2]Restricted stock award will vest 100% on March 23, 2024.
Documents
Issuer
CUMBERLAND PHARMACEUTICALS INC
CIK 0001087294
Entity typeother
Related Parties
1- filerCIK 0001666790
Filing Metadata
- Form type
- 4
- Filed
- Apr 16, 8:00 PM ET
- Accepted
- Apr 17, 5:18 PM ET
- Size
- 6.3 KB